Drug manufacturers.
Active 2019–2023.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2023 | THORN RUN PARTNERS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$60,000 | |
| 2023 | THORN RUN PARTNERS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | |
| 2023 | THORN RUN PARTNERS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | |
| 2023 | THORN RUN PARTNERS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$60,000 | |
| 2022 | THORN RUN PARTNERS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$60,000 | |
| 2022 | THORN RUN PARTNERS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | |
| 2022 | THORN RUN PARTNERS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | |
| 2022 | THORN RUN PARTNERS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$40,000 | |
| 2022 | THORN RUN PARTNERS |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | |
| 2019 | THORN RUN PARTNERS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
$10,000 |
| Firm | Filings | Amount |
|---|---|---|
| THORN RUN PARTNERS | 14 | $580,000 |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 11 |
| Health Issues | 5 |